# FDA Inspection 1027701 - Biomat USA Inc - August 15, 2017

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/594eb0aa-9695-41dc-944e-41a5506c025a
Source feed: FDA_Inspections

> FDA Inspection 1027701 for Biomat USA Inc on August 15, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1027701
- Company Name: Biomat USA Inc
- Inspection Date: 2017-08-15
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 938990 - 2015-08-20](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/b2946c67-31d0-42a8-8013-8914734a7ab2)
- [FDA Inspection 772821 - 2012-03-09](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/32c13d15-ccc3-4aa4-9deb-6b125c461755)

Company: https://www.keypedia.com/companies/biomat-usa-inc/09837e3e-6d38-434a-acd1-a0ed2ca93027

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d